We specifically showed that IL9-polarized TAMs induced antitumor immunity in mice by recruiting antitumor immune cells into the tumor mass via releasing the macrophage-derived chemoattractants, CCL3/4 and CXCL9/10. The gene discussed is CCL3; the disease is neoplasm.